Does Abatacept Induce Testicular Toxicity?

Sultan AL-MOGAIREN

DOI: 10.46497/ArchRheumatol.2020.7164

Issue: Volume 35 - Issue 2 - June 2020
1591 1587

Serum C-Reactive Protein/Albumin Ratio in Rheumatoid Arthritis and its Relationship With Disease Activity, Physical Function, and Quality of Life

İsmihan SUNAR, Şebnem ATAMAN

DOI: 10.46497/ArchRheumatol.2020.7456

Issue: Volume 35 - Issue 2 - June 2020
2791 2057

Spontaneous Spinal Epidural Hematoma During Simultaneous Tocilizumab and Warfarin Use in a Patient With Rheumatoid Arthritis: Is There a Drug Interaction Between Tocilizumab and Oral Anticoagulants?

Seçilay GÜNEŞ, Haydar GÖK, Şebnem ATAMAN, Şehim KUTLAY

DOI: 10.46497/ArchRheumatol.2020.7579

Issue: Volume 35 - Issue 4 - December 2020
1849 1650

Obesity and Remission Rates in Japanese Patients With Rheumatoid Arthritis Requiring Anti-Tumor Necrosis Factor Alpha Therapy

Kenji YAMAZAKI, Etsuji SUZUKI, Ryuhei ISHIHARA, Toshiaki MIYAMOTO

DOI: 10.46497/ArchRheumatol.2020.7852

Issue: Volume 35 - Issue 4 - December 2020
1899 2073

Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis

Ümit SARP, Evren ÜSTÜNER, Sehim KUTLAY, Şebnem ATAMAN, Sim KUTLAY

DOI: 10.46497/ArchRheumatol.2020.7868

Issue: Volume 35 - Issue 3 - September 2020
1869 1760

Change of ARASHI scores for large joints in rheumatoid arthritis patients treated with abatacept for three years: A clinical observational study

Takeshi MOCHIZUKI, Koichiro YANO, Katsunori IKARI, Ryo HIROSHIMA, Mina ISHIBASHI, Ken OKAZAKI

DOI: 10.46497/ArchRheumatol.2021.7727

Issue: Volume 36 - Issue 1 - March 2021
1186 1886

Knowledge of cardiovascular disease risk in rheumatoid arthritis patients before and after educational intervention from a Southeast Asia country: Malaysia

Boon Ching TEOH, Syed Azhar SYED SULAIMAN, Bee Eng TAN

DOI: 10.46497/ArchRheumatol.2021.7726

Issue: Volume 36 - Issue 1 - March 2021
1199 2210

Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks

Murat KARKUCAK, Mehmet KOLA, Ahmet KALKIŞIM, Erhan ÇAPKIN, Ahmet AYAR, Adem TÜRK

DOI: 10.46497/ArchRheumatol.2021.7806

Issue: Volume 36 - Issue 1 - March 2021
1471 1901

Joint Surgery in Tunisian Rheumatoid Arthritis Patients: Prevalence and Risk Factors

Olfa SAIDANE, Leila GAFSI, Aicha Ben TEKAYA, Ines MAHMOUD, Rawdha TEKAYA, Leila ABDELMOULA

DOI: 10.46497/ArchRheumatol.2020.7483

Issue: Volume 35 - Issue 3 - September 2020
1332 1465

A cross-sectional study of sexual dysfunction in chinese mainland female patients with rheumatoid arthritis

Congcong ZHOU

DOI: 10.46497/ArchRheumatol.2021.8074

Issue: Volume 36 - Issue 2 - June 2021
1007 1552

Patients with rheumatoid arthritis and osteoarthritis in terms of sex hormone receptors and histopathological comparison of features

Turgut KÜLTÜR, Mehmet ZENGİN

DOI: 10.46497/ArchRheumatol.2021.8242

Issue: Volume 36 - Issue 2 - June 2021
975 1724

Assessment of subclinical atherosclerosis with ankle-brachial index in psoriatic arthritis: A case-control study

Serhad BİLİM, Afitap İÇAĞASIOĞLU, Ayla AKBAL, Esen KASAPOĞLU, Sıdıka GÜRSEL

DOI: 10.46497/ArchRheumatol.2021.8083

Issue: Volume 36 - Issue 2 - June 2021
1102 1596

Comparisons of +3179G/A insulin-like growth factor 1 receptor gene distribution between two inflammatory arthritides and healthy adults

Mariana IVANOVA, Irena MANOLOVA, Rumen STOILOV, Spaska STANILOVA

DOI: 10.46497/ArchRheumatol.2021.8234

Issue: Volume 36 - Issue 2 - June 2021
891 1419

Evaluating various radiographic methods of shoulder joint damage in patients with rheumatoid arthritis receiving biological disease-modifying antirheumatic drugs

Kazuhito Sugimori, Isao Matsushita, Tomoatsu Kimura

DOI: 10.46497/ArchRheumatol.2021.8236

Issue: Volume 36 - Issue 3 - September 2021
1231 1418

Kinesiophobia in rheumatoid arthritis patients: Relationship with quadriceps muscle strength, fear of falling, functional status, disease activity, and quality of life

İlkay Baysalhan Öztürk, Yeşim Garip, Filiz Sivas, Merve Parlak Özden, Hatice Bodur

DOI: 10.46497/ArchRheumatol.2021.8535

Issue: Volume 36 - Issue 3 - September 2021
2758 2033

Attitudes of patients with spondylarthritis or rheumatoid arthritis regarding biological treatment during COVID-19 pandemic: A multi-center, phone-based, cross-sectional study

Coskun Zateri, Murat Birtane, İlknur Aktaş, Selda Sarıkaya, Aylin Rezvani, Lale Altan, Nigar Dursun, Erbil Dursun, Nurettin Taştekin, Reyhan Çeliker, Şenay Özdolap, Kenan Akgün

DOI: 10.46497/ArchRheumatol.2021.8364

Issue: Volume 36 - Issue 4 - December 2021
1442 1839

Patient perspectives on biological treatments for inflammatory arthritis: A multi-center study in Korea

In Ah Choi, Ji Hyoun Kim, Sung Hae Chang, Ran Song, You-Jung Ha, Hye Won Kim, Jeong Seok Lee, Byoongyong Choi, Yoon-Jeong Oh, Ki Won Moon

DOI: 10.46497/ArchRheumatol.2021.8524

Issue: Volume 36 - Issue 4 - December 2021
1291 2045

Peer-led education or booklet for knowledge transfer about disease: A randomized-controlled trial with ankylosing spondylitis patients

Taciser Kaya, Pınar Atıcı, Altınay Göksel Karatepe, Rezzan Günaydın

DOI: 10.46497/ArchRheumatol.2021.8334

Issue: Volume 36 - Issue 4 - December 2021
1025 1293

Missense variant in interleukin-6 signal transducer identified as susceptibility locus for rheumatoid arthritis in Chinese patients

Khai Pang Leong, Mei Yun Yong, Liuh Ling Goh, Chia Mun Woo, Chia Wei Lim, Ee Tzun Koh

DOI: 10.46497/ArchRheumatol.2021.8127

Issue: Volume 36 - Issue 4 - December 2021
793 1357

Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study

Emine Müge Acar, Senem Şaş, Fatmanur Aybala Koçak

DOI: 10.46497/ArchRheumatol.2022.8645

Issue: Volume 37 - Issue 2 - June 2022
6694 1829